cysteine has been researched along with tamoxifen in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Katzenellenbogen, BS; Reese, JC; Wooge, CH | 1 |
| Greene, GL; Harlow, KW; Katzenellenbogen, BS; Katzenellenbogen, JA; Smith, DN | 1 |
| Katzenellenbogen, BS; Sheen, YY | 1 |
| Attardi, B | 1 |
| Anker, G; Lien, EA; Lønning, PE; Refsum, H; Ueland, PM | 1 |
| Katzenellenbogen, BS; Le Goff, P; Pakdel, F | 1 |
| Aliau, S; Borgna, JL; Mattras, H; Richard, E | 1 |
| Belame, A; Burow, ME; Carrier, L; Li, Z; Rowan, BG; Salvo, VA; Thiyagarajah, A | 1 |
| Bosello, V; Conrad, M; Maiorino, M; Mannes, AM; Seiler, A | 1 |
| Blanco, MD; Iglesias, I; Martínez, A; Muñiz, E; Teijón, JM | 1 |
| Choi, YH; Lee, MG; Lee, YK; Yoon, I | 1 |
| Kang, KW; Kim, SK; Kwak, HC; Lee, JY; Oh, SJ; Phuong, NT; Ryu, CS | 1 |
| Blanco, MD; Iglesias, I; Martínez, A; Muñiz, E; Teijón, C; Teijón, JM | 1 |
| Honma, Y; Okuni, N; Tamura, K; Urano, T | 1 |
| Katsumi, H; Morishita, M; Moroto, Y; Nomura, D; Ogawa, K; Yamamoto, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for cysteine and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for cysteine and tamoxifen
| Article | Year |
|---|---|
Identification of two cysteines closely positioned in the ligand-binding pocket of the human estrogen receptor: roles in ligand binding and transcriptional activation.
Topics: Base Sequence; Binding Sites; Cysteine; Humans; Ligands; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein Binding; Receptors, Estrogen; Tamoxifen; Transcription, Genetic | 1992 |
Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor.
Topics: Affinity Labels; Alkylation; Aziridines; Binding Sites; Chromatography, High Pressure Liquid; Cyanogen Bromide; Cysteine; Humans; Ketones; Peptide Fragments; Receptors, Estrogen; Serine Endopeptidases; Tamoxifen; Trypsin; Tumor Cells, Cultured | 1989 |
Antiestrogen stimulation of the production of a 37,000 molecular weight secreted protein and estrogen stimulation of the production of a 32,000 molecular weight secreted protein in MCF-7 human breast cancer cells.
Topics: Amino Acids; Breast Neoplasms; Cell Line; Cysteine; Estradiol; Female; Humans; Kinetics; Methionine; Molecular Weight; Neoplasm Proteins; Sulfur Radioisotopes; Tamoxifen | 1987 |
Effects of sulfhydryl reagents on uterine nuclear estrogen receptors labeled by in vitro exchange with [3H]estradiol or [3H]4-hydroxytamoxifen.
Topics: Animals; Cell Nucleus; Cysteine; Estradiol; Female; Glutathione; Glutathione Disulfide; In Vitro Techniques; Rats; Receptors, Estrogen; Sulfhydryl Reagents; Tamoxifen; Uterus | 1984 |
Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen.
Topics: Aged; Arteriosclerosis; Breast Neoplasms; Cholesterol; Cysteine; Female; Folic Acid; Homocysteine; Humans; Menopause; Middle Aged; Tamoxifen; Time Factors; Vitamin B 12 | 1995 |
An assessment of the role of domain F and PEST sequences in estrogen receptor half-life and bioactivity.
Topics: Algorithms; Amino Acid Sequence; Animals; Base Sequence; Cell Line; Chlorocebus aethiops; CHO Cells; Cricetinae; Cysteine; DNA Primers; Half-Life; Humans; Kidney; Kinetics; Methionine; Molecular Sequence Data; Mutagenesis, Site-Directed; Phosphorylation; Receptors, Estrogen; Software; Sulfur Radioisotopes; Tamoxifen; Time Factors; Transfection; Tritium | 1993 |
Cysteine 530 of the human estrogen receptor alpha is the main covalent attachment site of 11beta-(aziridinylalkoxyphenyl)estradiols.
Topics: Animals; Aziridines; Binding Sites; Binding, Competitive; COS Cells; Cysteine; Estradiol; Estrogen Receptor alpha; Female; Humans; Ligands; Receptors, Estrogen; Sheep; Tamoxifen; Uterus | 1999 |
Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Division; Cyclin D1; Cysteine; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neovascularization, Pathologic; Organoselenium Compounds; Random Allocation; Receptors, Progesterone; Selenocysteine; Specific Pathogen-Free Organisms; Tamoxifen; Xenograft Model Antitumor Assays | 2009 |
Cysteine mutant of mammalian GPx4 rescues cell death induced by disruption of the wild-type selenoenzyme.
Topics: Animals; Biocatalysis; Blotting, Western; Cell Hypoxia; Cell Proliferation; Cell Survival; Cells, Cultured; Cysteine; Doxycycline; Gene Expression Regulation, Enzymologic; Glutathione Peroxidase; HEK293 Cells; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutant Proteins; Mutation; Phospholipid Hydroperoxide Glutathione Peroxidase; Reverse Transcriptase Polymerase Chain Reaction; Selenocysteine; Selenoproteins; Tamoxifen | 2011 |
Enhanced preclinical efficacy of tamoxifen developed as alginate-cysteine/disulfide bond reduced albumin nanoparticles.
Topics: Alginates; Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cysteine; Disulfides; Female; Glucuronic Acid; Hexuronic Acids; Humans; Mice; Mice, Nude; Nanoparticles; Neoplasms; Ovary; Serum Albumin, Bovine; Tamoxifen; Tumor Burden; Uterus; Xenograft Model Antitumor Assays | 2012 |
Effects of cysteine on the pharmacokinetics of tamoxifen in rats with protein-calorie malnutrition.
Topics: Administration, Intravenous; Administration, Oral; Animals; Bile; Biological Transport; Blood Proteins; Cysteine; Dialysis; Energy Intake; Feeding Behavior; Intestinal Absorption; Intestinal Mucosa; Intestines; Kinetics; Male; Microsomes, Liver; Protein Binding; Protein-Energy Malnutrition; Rats; Rats, Sprague-Dawley; Tamoxifen; Weight Gain | 2012 |
Elevation of cysteine consumption in tamoxifen-resistant MCF-7 cells.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cystathionine gamma-Lyase; Cysteine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Glutamate-Cysteine Ligase; Glutathione; Humans; Membrane Transport Modulators; Methionine; Methylation; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; S-Adenosylhomocysteine; S-Adenosylmethionine; Tamoxifen; Taurine; Up-Regulation | 2013 |
Targeting tamoxifen to breast cancer xenograft tumours: preclinical efficacy of folate-attached nanoparticles based on alginate-cysteine/disulphide-bond-reduced albumin.
Topics: Albumins; Alginates; Animals; Breast Neoplasms; Cysteine; Disulfides; Folic Acid; Glucuronic Acid; Hexuronic Acids; Humans; MCF-7 Cells; Mice; Mice, Nude; Nanoparticles; Tamoxifen; Xenograft Model Antitumor Assays | 2014 |
Romidepsin and tamoxifen cooperatively induce senescence of pancreatic cancer cells through downregulation of FOXM1 expression and induction of reactive oxygen species/lipid peroxidation.
Topics: alpha-Tocopherol; Animals; Cell Line, Tumor; Cell Proliferation; Cysteine; Depsipeptides; Down-Regulation; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Humans; Lipid Peroxidation; Pancreatic Neoplasms; Reactive Oxygen Species; Tamoxifen | 2022 |
A Dense Layer of Polyethyleneglycol and Zwitterionic Bone Targeting Peptide on the Surface of Stereocomplex Polylactide-Polyethyleneglycol Nanoparticles Improves Shelf-storage Stability and the Serum Compatibility.
Topics: Animals; Aspartic Acid; Cysteine; Hydroxyapatites; Lysine; Mice; Nanoparticles; Peptides; Polyesters; Polyethylene Glycols; Protein Corona; Tamoxifen | 2022 |